Pangrol Lipázy (Pancreas Powder From Porcine)

Pangrol Lipázy is an enzyme preparation that acts on the digestive system to aid nutrient breakdown.

• Pancreatic exocrine insufficiency: Improves digestion of fats, proteins and carbohydrates.
• Cystic fibrosis related malabsorption: Enhances absorption of nutrients.
• Chronic pancreatitis: Supports digestive enzyme replacement therapy.
• Post‑surgical pancreatic resection: Assists in maintaining nutritional status.
• Small‑intestinal bacterial overgrowth (SIBO) adjunct: May reduce symptoms when combined with antimicrobial therapy.

• Pancreas powder from porcine provides a mixture of pancreatic enzymes—including amylase, lipase and proteases—that act within the intestinal lumen to hydrolyze carbohydrates, fats and proteins into absorbable molecules. The enzymes are derived from porcine pancreatic tissue and retain activity after oral administration, compensating for deficient endogenous secretion.

Adverse reactions to pancreatic enzyme powders are generally mild and related to gastrointestinal tolerance.

Common Side Effects

• Abdominal discomfort: Mild cramping or bloating.
• Flatulence: Increased intestinal gas.
• Nausea: Transient feeling of queasiness.
• Diarrhea: Loose stools, often mild.
• Constipation: Hard stools in some patients.
• Taste alteration: Slight metallic or bitter aftertaste.

Serious or Rare Side Effects

• Fibrosing colonopathy: Rare narrowing of the colon associated with high‑dose therapy.
• Allergic reaction: Rash, itching, swelling or anaphylaxis.
• Pancreatitis exacerbation: Worsening of underlying pancreatic inflammation.
• Respiratory symptoms: Cough or wheeze indicating aspiration.
• Severe abdominal pain: Persistent pain requiring medical evaluation.

When prescribing Pangrol Lipázy, clinicians should consider several safety aspects.

• Dose titration: Adjust based on clinical response and stool characteristics.
• Monitoring: Regularly assess nutritional status and growth in pediatric patients.
• Acid suppression: Concomitant proton‑pump inhibitors may improve enzyme activation.
• Allergies: Avoid in patients with known porcine protein hypersensitivity.
• Pregnancy and lactation: Use only if the benefit outweighs potential risk.
• Store at ambient temperature: Keep below 25°C, in the original container, protected from moisture and direct sunlight.

Pancreatic enzyme powders can interact with other medications that affect gastric acidity or gastrointestinal motility.

Major Interactions (Avoid)

• Proton‑pump inhibitors: May reduce enzyme activation if taken without an acidic environment.
• Antacids containing aluminum or magnesium: Can bind enzymes and lower efficacy.

Moderate Interactions (Monitor Closely)

• Oral corticosteroids: May increase risk of gastrointestinal irritation.
• Antibiotics for SIBO: May alter gut flora and affect enzyme performance.
• Lipid‑lowering agents (e.g., orlistat): Compete for the same substrate in the lumen.
• Diabetes medications: Improved carbohydrate digestion can affect glycemic control.
• Bile acid sequestrants: May interfere with fat digestion and enzyme activity.